RichLink has been Hired by Kissei for Medical Content Service
Japanese Pharmaceutical Manufacturer Introduces RichLink to Enhance Online Experience for Japanese Medical Professionals
(PRWEB) February 8, 2003
Silicon Valley software developer Sentius Corporation today announced that leading Japanese pharmaceutical manufacturer KISSEI Pharmaceutical, Co., Ltd., has launched the Sentius RichLink Medical Content Service™. Kissei chose the RichLink platform to enhance point-of-care communication for medical professionals on Kissei's Web site.
The RichLink Medical Content Service combines publishers' data with a patented way to deliver content through Web application usability technology. Kissei uses the RichLink Medical Content Service to merge relevant clinical gynecological and dermatological information from Reuters Health News with Japanese medical glossaries. Kissei believes Sentius' software will provide substantially improved delivery of relevant information to medical professionals, and RichLink keeps readers engaged on Kissei Web site, improves their comprehension, and gives them a more rewarding online experience with relevant news and information.
When a physician clicks on an unfamiliar gynecological term on the Kissei Web site, a Japanese language annotation appears adjacent to the page. RichLink 4.0 makes it possible for Japanese healthcare professionals to get contextual information in their primary language when and where they want that information without leaving the page they are on.
Sentius' research shows that users are six times more likely to find the information they need using dynamic contextual linking provided by RichLink.
“RichLink is a valuable technology that gives our customers easier and more intuitive access to our health and medical news stories,” said Reuters Health, President and CEO, Dan McKillen. “Our customers are becoming increasingly aware that contextual content is where it’s all headed.”
Reuters Health News supplies worldwide wires that are written specifically for health care professionals. The health news wire service is available to over 80 different vertical medical specialties. “The combination of superior content from Reuters Health with RichLink’s patented usability technology will keep people engaged on Kissei’s Web site," said Sentius CEO Marc Bookman.
About Kissei
Kissei Pharmaceutical Company is a leading R&D-oriented pharmaceutical and medical supply company headquartered in Nagano, Japan. With offices in Japan, Europe and the United States, Kissei Pharmaceutical has more than 1,400 employees. The CompanyÂ’s main areas of research and development include those related to immunology, endocrinology, cardiology, urogenital systems, and ophthalmology. For more information, visit http://www. kissei. co. jp (http://www. kissei. co. jp).
About RichLinkTM
RichLinkTM, created by Sentius Corporation, is Web application usability software that automates and centralizes the management of links at the word, phrase, and metadata level. RichLink is Dynamic Contextual Linking (DCL) technology that enables intelligent delivery of relevant content and functions to users within the context of their active workspace. RichLink maps the content you already have; tags that content automatically; and serves content that lets users find the information they need without leaving the page. RichLink usually can be set up in a single workday and significantly increases return on investment in existing Web infrastructure. RichLink requires no plug-ins or desktop software to download and works across virtually every browser, platform, and operating system. Sentius Corporation is located in Palo Alto, California. For more information, visit http://www. richlink. com (http://www. richlink. com)
RichLink is a trademark of Sentius Corporation and/or its affiliates.
# # #
